Pretreatment attrition and childhood social phobia: Parental concerns about medication

Journal of Anxiety Disorders

Volumn 20, Issue 8, 2006, Pages 1133-1147

  Young, Brennan J ^a   Beidel, Deborah C ^a   Turner, Samuel M ^a   Ammerman, Robert T ^b   McGraw, Kelly ^b   Coaston, Susannah C ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Behavioral treatment; Children; Pharmacological treatment; Social anxiety disorder; Study attrition

Indexed keywords

FLUOXETINE; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; DRUG DEPENDENCE; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARENT; PARENTAL ATTITUDE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SOCIAL PHOBIA; TREATMENT REFUSAL;

ADOLESCENT; ATTITUDE TO HEALTH; BEHAVIOR THERAPY; CHILD; FEMALE; FLUOXETINE; HUMANS; MALE; PARENTS; PHOBIC DISORDERS; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS;

EID: 33750496012     PISSN: 08876185     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.janxdis.2006.03.007     Document Type: Article

References (32)

1. Beidel D.C., Turner S.M., Young B.J., and Paulson A. Social effectiveness therapy for children: three-year follow-up. Journal of Consulting and Clinical Psychology 73 4 (2005) 721-725
2. Bennett D.S., Power T.J., Rostain A.L., and Carr D.E. Parent acceptability and feasibility of ADHD interventions: assessment, correlates, and predictive validity. Journal of Pediatric Psychology 21 5 (1996) 643-657
3. Birmaher B., Axelson D.A., Monk K., Kalas C., Clark D.B., Ehmann M., et al. Fluoxetine for the treatment of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry 42 4 (2003) 415-423
4. Breggin P.R. Suicidality, violence, and mania caused by selective serotonin reuptake inhibitors: a review and analysis. Ethical Human Sciences and Services 5 3 (2003) 225-246
5. Cartwright-Hatton S., Roberts C., Chitsabesan P., Fothergill C., and Harrington R. Systematic review of the efficacy of cognitive behaviour therapies for childhood and adolescent anxiety disorders. British Journal of Clinical Psychology 43 4 (2004) 421-436
6. Chavira D.A., Stein M.B., Bailey K., and Stein M.T. Parental opinions regarding treatment for social anxiety disorder in youth. Journal of Developmental & Behavioral Pediatrics 24 5 (2003) 315-322
7. Coles M.E., Turk C.L., Jindra L., and Heimberg R.G. The path from initial inquiry to initiation of treatment for social anxiety disorder in an anxiety disorders speciality clinic. Journal of Anxiety Disorders 18 3 (2004) 371-383
8. Crawley L. African-American participation in clinical trials: situating trust and trustworthiness. Journal of the National Medical Association 93 12 (2001) 14S-17S
9. Evelyn B., Toigo T., Banks D., Pohl D., Gray K., Robins B., et al. Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999. Journal of the National Medical Association 93 12 (2001) 18S-24S
10. Graham J.W., and Donaldson S.I. Evaluating interventions with differential attrition: the importance of nonresponse mechanisms and use of follow-up data. Journal of Applied Psychology 78 1 (1993) 119-128
11. Hansen W.B., Collins L.M., Malotte C.K., Johnson C.A., and Fielding J.E. Attrition in prevention research. Journal of Behavioral Medicine 8 3 (1985) 261-275
12. Hofmann S.G., Barlow D.H., Papp L.A., Detweiler M.F., Ray S.E., Shear M.K., et al. Pretreatment attrition in a comparative treatment outcome study on panic disorder. American Journal of Psychiatry 155 1 (1998) 43-47
13. Hudson J.L., Deveney C., and Taylor L. Nature, assessment and treatment of generalized anxiety disorder in children. Pediatric Annals 34 2 (2005) 97-106
14. Huppert J.D., Franklin M.E., Foa E.B., and Davidson J.T. Study refusal and exclusion from a randomized treatment study of generalized social phobia. Journal of Anxiety Disorders 17 6 (2003) 683-693
15. Issakidis C., and Andrews G. Pretreatment attrition and dropout in an outpatient clinic for anxiety disorders. Acta Psychiatrica Scandinavica 109 6 (2004) 426-433
16. Kazdin A.E. Acceptability of alternative treatments for child deviant behavior. Journal of Applied Behavioral Analysis 13 2 (1980) 259-273
17. Kendall P.C., Safford S., Flannery-Schroeder E., and Webb A. Child anxiety treatment: outcomes in adolescence and impact on substance use and depression at 7.4 year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry 72 2 (2004) 276-287
18. Lin K.M., Inui T.S., Kleinman A.M., and Womach W.M. Sociocultural determinants of the help-seeking behavior of patients with mental illness. Journal of Nervous and Mental Disease 170 2 (1982) 78-85
19. Lynch G.F., Gorelick P.B., Raman R., and Leurgans S. A pilot survey of African-American physician perceptions about clinical trials. Journal of the National Medical Association 92 12 (2001) 8S-13S
20. Mavissakalian M.R., and Zamar N. Generalized anxiety disorder versus panic disorder: participation in controlled efficacy trials. Comprehensive Psychiatry 41 4 (2000) 253-258
21. McClellan J.M., and Werry J.S. Evidence-based treatments in child and adolescent psychiatry: an inventory. Journal of the American Academy of Child and Adolescent Psychiatry 42 12 (2003) 1388-1400
22. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry 56 12 (1999) 1073-1086
23. Nutt D.J. Death and dependence: current controversies over the selective serotonin reuptake inhibitors. Journal of Psychopharmacology 17 4 (2003) 355-364
24. Pederson P.B. The multicultural context of mental health. In: Smith T.B. (Ed). Practicing multiculturalism: affirming diversity in counseling and psychology (2004), Pearson Education, Inc, USA
25. Pine D.S. Treating children and adolescents with selective serotonin reuptake inhibitors: how long is appropriate?. Journal of Child and Adolescent Psychopharmacology 12 3 (2002) 189-203
26. Silverman W., and Albano A. The anxiety disorders interview schedule for children (ADIS-C/P) (1996), Psychological Corporation, San Antonio, TX
27. Takeuchi D.T., Bui K.T., and Kim L. The referral of minority adolescents to community mental health centers. Journal of Health and Social Behavior 34 2 (1993) 153-164
28. Tarnowski K.J., Rasnake L.K., Mulick J.A., and Kelly P.A. Acceptability of behavioral treatments for self-injurious behavior. American Journal of Mental Retardation 93 5 (1989) 575-580
29. Tarnowski K.J., Simonian S.J., Bekeny P., and Park A. Acceptability of interventions for childhood depression. Behavior Modification 16 1 (1992) 103-117
30. Treatment for Adolescents with Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression. Journal of the American Medical Association 292 7 (2004) 807-820
31. Wagner K.D., Berard R., Stein M.B., Wetherhold E., Carpenter D.J., Perera P., et al. A multi-center, randomized, double-blind, placebo-controlled, trial of paroxetine in children and adolescents with social anxiety disorder. Archives of General Psychiatry 61 11 (2004) 1153-1162
32. Woods M.N., Harris K.J., Mayo M.S., Catley D., Scheibmeir M., and Ahluwalia J.S. Participation of African Americans in a smoking cessation trial: a quantitative and qualitative study. Journal of the National Medical Association 94 7 (2002) 609-618